SS
MTNB icon

Simplicity Solutions’s Matinas BioPharma MTNB Stock Holding History

Simplicity Solutions’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$13K Hold
80
– – ﹤0.01% 1065
2023
Q3 		$7.8K Hold
80
– – ﹤0.01% 989
2023
Q2 		$21.6K Hold
80
– – ﹤0.01% 1046
2023
Q1 		$28.2K Buy
+80
New +$30.3K ﹤0.01% 1119
2019
Q3 		– Sell
-27
Closed -$17K – 757
2019
Q2 		$17K Buy
+27
New +$19.5K ﹤0.01% 652

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MSFS
Main Street Financial Solutions Newtown, Pennsylvania $1.56B AUM 24.84% 1-Year Est. Return

Simplicity Solutions's MTNB Position: Q4 2023 in Review

Simplicity Solutions held its Matinas BioPharma (MTNB) position steady in Q4 2023 at 80 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1065.

Simplicity Solutions first reported a position in MTNB in Q2 2019 and has held it in 5 quarters since. The position peaked at $28.2K in Q1 2023. 50 funds tracked by Wall St. Rank hold MTNB as of Q4 2023.

  • Simplicity Solutions held 80 shares of Matinas BioPharma worth $13K as of Q4 2023.
  • Simplicity Solutions left its Matinas BioPharma share count unchanged in Q4 2023.
  • Matinas BioPharma made up ﹤0.01% of Simplicity Solutions's portfolio in Q4 2023, its #1065 holding.
  • Simplicity Solutions first reported a position in Matinas BioPharma in Q2 2019 and has held it in 5 quarters since.
  • Simplicity Solutions's Matinas BioPharma position peaked at $28.2K in Q1 2023.
  • 50 funds tracked by Wall St. Rank held Matinas BioPharma as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.